Cargando…
Ventricular arrhythmia management in patients with genetic cardiomyopathies
Genetic cardiomyopathies are associated with increased risk for cardiac arrhythmias and sudden cardiac death. The management of ventricular arrhythmias (VAs) in patients with these conditions can be nuanced due to particular disease-based considerations, yet data specifically addressing management i...
Autores principales: | Sharif, Zain I., Lubitz, Steven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710624/ https://www.ncbi.nlm.nih.gov/pubmed/34988533 http://dx.doi.org/10.1016/j.hroo.2021.10.009 |
Ejemplares similares
-
Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021) -
Management of ventricular arrhythmias in heart failure: Current perspectives
por: Peichl, Petr, et al.
Publicado: (2021) -
Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes into clinical care
por: Sandhu, Uday, et al.
Publicado: (2021) -
Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experience
por: Toniolo, Mauro, et al.
Publicado: (2021) -
Artificial Intelligence in Ventricular Arrhythmias and Sudden Death
por: Holmström, Lauri, et al.
Publicado: (2023)